Spyre Therapeutics
SYRE
#3830
Rank
S$4.34 B
Marketcap
S$55.96
Share price
2.24%
Change (1 day)
97.08%
Change (1 year)

EPS for Spyre Therapeutics (SYRE)

EPS in 2025 (TTM): S-$2.91

According to Spyre Therapeutics's latest financial reports the company's current EPS (TTM) is S-$2.79. In 2024 the company made an earnings per share (EPS) of S-$4.72.

EPS history for Spyre Therapeutics from 2024 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$2.91-38.25%
2024S-$4.72